Gene · 79885
Papers2,024
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,024
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging roles of activating transcription factor 2 in the development of breast cancer: a comprehensive review. | Precis Clin Med | 2023 | 37955015 | PubTator, text mining | PubMed |
| Regulatory mechanisms of one-carbon metabolism enzymes. | J Biol Chem | 2023 | 37949226 | PubTator, text mining | PubMed |
| Epigenetic modulations of immune cells: from normal development to tumor progression. | Int J Biol Sci | 2023 | 37928272 | PubTator, text mining | PubMed |
| Seven chromatin regulators as immune cell infiltration characteristics, potential diagnostic biomarkers and drugs prediction in hepatocellular carcinoma. | Sci Rep | 2023 | 37903974 | PubTator, text mining | PubMed |
| The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis. | Int J Mol Sci | 2023 | 37894746 | PubTator, text mining | PubMed |
| HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression. | Redox Biol | 2023 | 37890360 | PubTator, text mining | PubMed |
| Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota. | Front Med (Lausanne) | 2023 | 37881635 | PubTator, text mining | PubMed |
| MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis. | Front Oncol | 2023 | 37854681 | PubTator, text mining | PubMed |
| LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. | J Exp Clin Cancer Res | 2023 | 37840133 | PubTator, text mining | PubMed |
| Histone and Histone Acetylation-Related Alterations of Gene Expression in Uninvolved Psoriatic Skin and Their Effects on Cell Proliferation, Differentiation, and Immune Responses. | Int J Mol Sci | 2023 | 37833997 | PubTator, text mining | PubMed |
| Clinical Potential of Cellular Material Sources in the Generation of iPSC-Based Products for the Regeneration of Articular Cartilage. | Int J Mol Sci | 2023 | 37833856 | PubTator, text mining | PubMed |
| Brain proteomic atlas of alcohol use disorder in adult males. | Transl Psychiatry | 2023 | 37833300 | PubTator, text mining | PubMed |
| HDAC11 mediates the ubiquitin-dependent degradation of p53 and inhibits the anti-leukemia effect of PD0166285. | Med Oncol | 2023 | 37805625 | PubTator, text mining | PubMed |
| End binding-3 inhibitor activates regenerative program in age-related macular degeneration. | Cell Rep Med | 2023 | 37794584 | PubTator, text mining | PubMed |
| Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma. | BMC Cancer | 2023 | 37789275 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Sideroflexin 4 in Hepatocellular Carcinoma by Bioinformatics and Experiments. | Int J Med Sci | 2023 | 37786439 | PubTator, text mining | PubMed |
| Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. | J Transl Med | 2023 | 37784157 | PubTator, text mining | PubMed |
| Unraveling the Complex Interplay between Epigenetics and Immunity in Alcohol-Associated Liver Disease: A Comprehensive Review. | Int J Biol Sci | 2023 | 37781509 | PubTator, text mining | PubMed |
| Recent advances in therapies for primary myelofibrosis. | Fac Rev | 2023 | 37771602 | PubTator, text mining | PubMed |
| Expression of the schizophrenia associated gene FEZ1 in the early developing fetal human forebrain. | Front Neurosci | 2023 | 37746155 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79885/papers?page=7